Artesunate effect on schistosome thioredoxin glutathione reductase and cytochrome c peroxidase as new molecular targets in schistosoma mansoni-infected mice

Biomedical and Environmental Sciences

Volumn 26, Issue 12, 2013, Pages 953-961

  Abdin, Amany A ^a   Ashour, Dalia S ^a   Shoheib, Zeinab S ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

Artesunate; Cytochrome c peroxidase; Praziquantel; Schistosomiasis; Thioredoxin glutathione reductase

Indexed keywords

ARTEMISININ DERIVATIVE; ARTESUNATE; CYTOCHROME C PEROXIDASE; MESSENGER RNA; MULTIENZYME COMPLEX; OXIDOREDUCTASE; PRAZIQUANTEL; THIOREDOXIN GLUTATHIONE REDUCTASE;

ANIMAL; ARTICLE; DRUG EFFECT; ENZYMOLOGY; GENETICS; MALE; MOUSE; POLYMERASE CHAIN REACTION; SCHISTOSOMA; SCHISTOSOMIASIS;

ARTESUNATE; CYTOCHROME C PEROXIDASE; PRAZIQUANTEL; SCHISTOSOMIASIS; THIOREDOXIN GLUTATHIONE REDUCTASE;

ANIMALS; ARTEMISININS; CYTOCHROME-C PEROXIDASE; MALE; MICE; MULTIENZYME COMPLEXES; NADH, NADPH OXIDOREDUCTASES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHISTOSOMA;

EID: 84892393850     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.3967/bes2013.030     Document Type: Article

References (76)

1. MJ van der Werf, SJ de Vlas, S Brooker et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa Acta Trop 86 2003 125 139
2. B Gryseels, K Polman, J Clerinx et al. Human schistosomiasis Lancet 368 2006 1106 1118
3. WHO Schistosomiasis. Fact sheet N 115 http://www.who.int/mediacentre/ factsheets/fs115/en/index.html 2010
4. P Steinmann, J Keiser, R Bos et al. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk Lancet Infect Dis 6 2006 411 425
5. B Gryseels Schistosomiasis vaccines: a devils' advocate view Parasitol Today 16 2000 46 48
6. M Lebens, JB Sun, C Czerkinsky et al. Current status and future prospects for a vaccine against schistosomiasis Expert Rev Vaccines 3 2004 315 328
7. OA Ismail Schistosomiasis Vaccines: Literature Review and Current Status PUJ 4 2011 137 154
8. PG Fallon, L-F Tao, MM Ismail et al. Schistosome resistance to praziquantel: Fact or artifact? Parasitology Today 12 1996 316 320
9. Z Xiaonong, C Minggang, D McManus et al. Schistosomiasis control in the 21st century. Proceedings of the International Symposium on Schistosomiasis, Shanghai, July 4-6, 2001 Acta Trop 82 2002 95 114
10. PJ Hotez, DH Molyneux, A Fenwick et al. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria: A comprehensive pro-poor health policy and strategy for the developing world PLoS Med 3 2006 e102
11. PG Fallon Schistosome resistance to praziquantel Drug Resist Updat 1 1998 236 241
12. MJ Doenhoff, JR Kusel, GC Coles et al. Resistance of Schistosoma mansoni to praziquantel: is there a problem? Trans R Soc Trop Med Hyg 96 2002 465 469
13. MJ Doenhoff, D Cioli, J Utzinger Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis Curr Opin Infect Dis 21 2008 659 667
14. CR Caffrey, WE Secor Schistosomiasis: from drug deployment to drug development Curr Opin Infect Dis 24 2011 410 417
15. AD Aragon, RA Imani, VR Blackburn et al. Microarray based analysis of temperature and oxidative stress induced messenger RNA in Schistosoma mansoni Mol Biochem Parasitol 162 2008 134 141
16. GM Mkoji, JM Smith, RK Prichard Antioxidant systems in Schistosoma mansoni: correlation between susceptibility to oxidant killing and the levels of scavengers of hydrogen peroxide and oxygen free radicals Int J Parasitol 18 1988 661 666
17. HM Alger, DL Williams The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase Mol Biochem Parasitol 121 2002 129 139
18. AN Kuntz, E Davioud-Charvet, AA Sayed et al. Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target PloS Med 4 2007 e206
19. F Angelucci, D Dimastrogiovanni, G Boumis et al. Mapping the catalytic cycle of Schistosoma mansoni thioredoxin glutathione reductase by X-ray crystallography J Biol Chem 285 2010 32557 32567
20. EG Campos, JM Smith, RK Prichard Cytochrome c peroxidase in Schistosoma mansoni enzyme kinetics and cellular location Comp Biochem Physiol 111 1995 371 377
21. DJ Chen, LF Fu, PP Shao et al. Studies on antischistosomal activity of qinghaosu in experimental therapy Chinese Med J 80 1980 422 428
22. Y Mitsui, M Miura, Y Aoki In vitro effects of artesunate on the survival of worm pairs and egg production of Schistosoma mansoni J Helminthol 83 2009 7 11
23. N Araújo, A Kohn, N Katz Therapeutic evaluation of artesunate in experimental Schistosoma mansoni infection Rev Soc Bras Med Trop 32 1999 7 12
24. D De Clercq, J Vercruysse, P Verlé et al. What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections? 5 2000 744 746
25. J Utzinger, J Chollet, JQ You et al. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals Acta Trop 80 2001 9 18
26. J Utzinger, J Chollet, Z Tu et al. Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice Trans R Soc Trop Med Hyg 96 2002 319 323
27. L Shaohong, T Kumagai, A Qinghua et al. Evaluation of the anthelmintic effects of artesunate against experimental Schistosoma mansoni infection in mice using different treatment protocols Parasitol Int 55 2006 63 68
28. SS Botros, MR Mahmoud, MM Moussa et al. Immunohistopathological and biochemical changes in Schistosoma mansoni-infected mice treated with artemether J Infect 55 2007 470 477
29. PC Inyang-Etoh, GC Ejezie, MF Useh et al. Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria Trans R Soc Trop Med Hyg 103 2009 38 44
30. A Nontprasert, M Nosten-Bertrand, S Pukrittayakamee et al. Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice Am J Trop Med Hyg 59 1998 519 522
31. M Xu The progress on prophylactic studies of artemisinin, artemether and artesunate against schistosomiasis japonica Chin J Schistosomiasis Control 10 1998 251 253
32. A Nontprasert, S Pukrittayakamee, M Nosten-Bertrand et al. Studies of the neurotoxicity of oral artemisinin derivatives in mice Am J Trop Med Hyg 62 2000 409 412
33. NJ White Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives Trans R Soc Trop Med Hyg 88 1994 41 43
34. Q Li, M Hickman Toxicokinetic and toxicodynamic (TK/TD) evaluation to determine and predict the neurotoxicity of artemisinins Toxicology 279 2011 1 9
35. KM Muraleedharan, MA Avery Progress in the development of peroxide based anti-parasitic agents. Drug Discovery Today Drug Discov Today 14 2009 793 803
36. FA Lewis, MA Stirewalt, CP Souza et al. Large-scale laboratory maintenance of Schistosoma mansoni, with observations on three schistosome snail host combination J Parasitol 772 1986 813 829
37. PA Peter, KS Warren A rapid method for infecting mice and other laboratory animals with subcutaneous injection J Parasitol 131 1969 558
38. R Chaiworaporn, Y Maneerat, W Rojekittikhun et al. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment Southeast Asian J Trop Med Public Health 36 2005 846 852
39. S Reagan-Shaw, M Nihal, N Ahmad Dose translation from animal to human studies revisited FASEB J 22 2008 659 661
40. RH Duvall, WB De Witt Technique for recovering adult schistosomes from laboratory animals Am J Trop Med Hyg 16 1967 438 486
41. AW Cheever Conditions affecting the accuracy of potassium hydroxide digestion in techniques for counting S. mansoni eggs in tissues Bull. World Health Organ 39 1968 328 331
42. IA Kamel, AW Cheever, AM Elwi et al. Schistosoma mansoni and S. haematobium infections in Egypt: technique for recovery of worms at necropsy Am J Trop Med Hyg 26 1977 696 701
43. R Abdul-Ghani, N Loutfy, A Hassan Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use Parasitol Res 105 2009 899 906
44. AA Sayed, A Simeonov, CJ Thomas et al. Identification of oxadiazoles as new drug leads for the control of schistosomiasis Nat Med 14 2008 407 412
45. F Angelucci, AE Miele, G Boumis et al. Macromolecular bases of antischistosomal therapy Curr Top Med Chem 11 2011 2012 2028
46. L Chiumiento, F Bruschi Enzymatic antioxidant systems in helminth parasites Parasitol Res 105 2009 593 603
47. M Maiorino, C Roche, M Kiess et al. A selenium-containing phospholipid-hydroperoxide glutathione peroxidase in Schistosoma mansoni Eur J Biochem 238 1996 838 844
48. H Mei, PT LoVerde Schistosoma mansoni: the developmental regulation and immunolocalization of antioxidants Exp Parasitol 86 1997 69 78
49. Y Guo, PS Xu, YX Xuan Observation of the effect of artesunate on ultrastructure of schistosomula Chin J Schistosomiasis Control 9 1997 34 35
50. PT LoVerde Do antioxidants play a role in schistosome host-parasite interactions? Parasitol Today 14 1998 284 289
51. GR Franco, AJG Simpson The structure and expression of the schistosome genom AAF Mahmoud Schistosomiasis 2001 Imperial College Press 85 114
52. P Scott, S James, A Sher The respiratory burst is not required for killing of intracellular and extracellular parasites by lymphocyte-activated mouse macrophages Eur J Immunol 15 1985 553 558
53. SF Ahmed, IP Oswald, P Caspar et al. Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni Infect Immun 65 1997 219 226
54. SM Neves, SA Rezende, AM Goes Nitric oxide-mediated immune complex-induced prostaglandin E(2) production by peripheral blood mononuclear cells of humans infected with Schistosoma mansoni Cell Immunol 195 1999 37 42
55. AC La Flamme, EA Patton, B Bauman et al. IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis J Immunol 166 2001 1903 1911
56. H Nahrevanian Involvement of nitric oxide and its up/down stream molecules in the immunity against parasitic infections Braz J Infect Dis 13 2009 440 448
57. R Abdul-Ghani, N Loutfy, M Sheta et al. Artemether shows promising female schistosomicidal and ovicidal effects on the Egyptian strain of Schistosoma mansoni after maturity of infection Parasitol Res 108 2011 1199 1205
58. PB Bartley, A Glanfield, Y Li et al. Artemether treatment of prepatent schistosoma japonicum induces resistance to reinfection in association with reduced pathology Am J Trop Med Hyg 78 2008 929 935
59. H Mehlhorn Encyclopedia of parasitology 3rd edition 2008 Springer Berlin 1542
60. NM El-Lakkany, SH Seif el-Din, AA Badawy et al. Effect of artemether alone and in combination with grapefruit juice on hepatic drugmetabolising enzymes and biochemical aspects in experimental Schistosoma mansoni Int J Parasitol 34 2004 1405 1412
61. MM Ismail, SA Taha, AM Farghaly et al. Laboratory induced resistance to praziquantel in experimental schistosomiasis J Egypt Soc Parasitol 24 1994 685 695
62. AD Aragon, RA Imani, VR Blackburn et al. Towards an understanding of the mechanism of action of praziquantel Mol Biochem Parasitol 164 2009 57 65
63. A Danso-Appiah, SJ de Vlas Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal Trends Parasitol 18 2002 125 129
64. G Ribeiro-dos-Santos, S Verjovski-Almeida, LC Leite Schistosomiasis-a century searching for chemotherapeutic drugs Parasitol Res 99 2006 505 521
65. P Andrews A summary of the efficacy of praziquantel against schistosomes in animal experiments and notes on its mode of action Arzneimittelforschung 31 1981 538 541
66. AA Sabah, C Fletcher, G Webbe et al. Schistosoma mansoni: chemotherapy of infection of different ages Exp Parasitol 61 1986 294 303
67. BL Herwaldt, LF Tao, W van Pelt et al. Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel Clin Infect Dis 20 1995 309 315
68. SQ Murray-Smith, BJ Scott, DP Barton et al. A case of refractory schistosomiasis Med J Aust 165 1996 458
69. M Ismail et al. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers Am J Trop Med Hyg 60 1999 932 935
70. X Shuhua, Y Jiqing, M Jinying et al. Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits Parasitol Int 49 2000 25 30
71. SH Vermund, DJ Bradley, E Ruiz-Tiben Survival of Schistosoma mansoni in the human host: Estimates from a community-based prospective study in Puerto Rico Am J Trop Med Hyg 32 1983 1040 1048
72. W Harnett, JR Kusel Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in vitro Parasitology 93 1986 401 405
73. CA Redman, A Robertson, PG Fallon et al. Praziquantel: an urgent and exciting challenge Parasitol Today 12 1996 14 20
74. SH Xiao Impact of host factors on the schistosome-killing process induced by praziquantel Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 26 2008 217 225 (In Chinese).
75. R Pax, JL Bennett, R Fetterer A benzodiazepine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum Naunyn-Schmiedebergs Arch Pharmacol 304 1978 309 315
76. MC Jeziorski, RM Greenberg Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action Int J Parasitol 36 2006 625 632